title: [Effect of urapidil therapy on insulin, glucagon, gastrin and pancreatic polypeptide secretion in patients with idiopathic arterial hypertension].
authors.forename: E
authors.initials: E
authors.lastname: Zukowska-Szczechowska
authors.forename: F
authors.initials: F
authors.lastname: Kokot
authors.forename: W
authors.initials: W
authors.lastname: Grzeszczak
authors.forename: A
authors.initials: A
authors.lastname: Wiecek
mesh_terms: D000328:Adult; D000959:Antihypertensive Agents; D005260:Female; D005755:Gastrins / Q000378:metabolism*; D005934:Glucagon / Q000378:metabolism; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000503:physiopathology; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D008297:Male; D008875:Middle Aged; D010187:Pancreatic Hormones / Q000378:metabolism*; D010191:Pancreatic Polypeptide / Q000037:antagonists & inhibitors / Q000378:metabolism; D010879:Piperazines / Q000627:therapeutic use*; D013268:Stimulation, Chemical
chemical_list: D000959:Antihypertensive Agents; D005755:Gastrins; D007328:Insulin; D010187:Pancreatic Hormones; D010879:Piperazines; D010191:Pancreatic Polypeptide; D005934:Glucagon; C015568:urapidil
vernacular_title: Wpływ leczenia urapidilem na wydzielanie insuliny, glukagonu, gastryny i polipeptydu trzustkowego u chorych na samoistne nadciśnienie tetnicze.